184 Followers on Owler

BioTheranostics is a molecular diagnostics company that provides prognostic and predictive testing solutions to treat breast and metastatic cancers...

Read more

BioTheranostics is a molecular diagnostics company that provides prognostic and predictive testing solutions to treat breast and metastatic cancers...

Read more
Biotheranostics Interim-CEO: Kevin R. Thornal

Interim-CEO

Kevin R. Thornal

CEO Approval Rating

82/100

Est. Annual Revenue
$25-100M
Agree?
Est. Employees
100-250
Agree?
Funding
32M

News

Feb 24, 2021
Clinical Lab Products
Biotheranostics: Hologic Completes Acquisition of Biotheranostics
Jan 19, 2021
GlobalNewswire
Press Release: Biotheranostics : Biotheranostics Announces Inclusion of Breast Cancer Index in the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines for Prediction of Benefit from Extended Endocrine Therapy
Jan 13, 2021
Genomeweb
Biotheranostics: Hologic Looks to Expand Profile in Breast Cancer Testing With Biotheranostics Acquisition
Jan 06, 2021
Medical Product Outsourcing
Biotheranostics: Hologic to Buy Cancer Test Maker Biotheranostics for $230M
Dec 30, 2020
StreetInsider
Press Release: Biotheranostics : UPDATE - Biotheranostics appoints Mark D. Pegram, MD as Chief Medical Consultant for Breast Oncology
Dec 08, 2020
GlobalNewswire
Press Release: Biotheranostics : Biotheranostics to premiere new data on Breast Cancer Index and prediction of endocrine therapy benefit at SABCS 2020
Sep 21, 2020
GlobalNewswire
Press Release: Biotheranostics : Biotheranostics CancerTYPE ID aids in patient selection for immunotherapy
Jul 27, 2020
GlobalNewswire
Press Release: Biotheranostics : Biotheranostics to Present at the LifeSci Partners Summer Symposium
May 15, 2020
StreetInsider
Press Release: Biotheranostics : Biotheranostics' Breast Cancer Index predicts benefit from two-and-a-half versus five years of extended endocrine therapy in HR+ breast cancer patients treated in the IDEAL trial
Apr 01, 2020
centralcharts
Press Release: Biotheranostics : Biotheranostics Announces Chief Commercial Officer

Biotheranostics Competitors

1
2
3
4
5
6
7
8
9
See 9+ competitors

Biotheranostics News

Biotheranostics Press Releases

Biotheranostics Headquarters

9640 Towne Centre Drive Suite 200

San Diego, California92121

1-877-886-6739

Driving Directions »

Biotheranostics Summary

ABOUT

Overview

BioTheranostics is a molecular diagnostics company that provides prognostic and predictive testing solutions to treat breast and metastatic cancers. Biotheranostics was founded in 2004. Biotheranostics' headquarters is located in San Diego, California...

CEO

Biotheranostics's Interim-CEO, Kevin R. Thornal, currently has an approval rating of 82%. Biotheranostics's primary competitors are Biocept, NanoString, Guardant Health and 6 more.

Acquisitions

There have been no acquisitions found related to Biotheranostics

Investments

Recent investment data cannot be found related to Biotheranostics

Frequently Asked Questions about Biotheranostics

  1. When was Biotheranostics founded?

    Biotheranostics was founded in 2004
  2. Who is Biotheranostics's CEO?

    Biotheranostics's CEO is Kevin R. Thornal
  3. How much revenue does Biotheranostics generate?

    Biotheranostics generates $33M in revenue
  4. How much funding does Biotheranostics have?

    Biotheranostics has historically raised $32M in funding
  1. Where is Biotheranostics's headquarters?

    Biotheranostics's headquarters is in San Diego California, USA
  2. How many employees does Biotheranostics have?

    Biotheranostics has 120 employees
  3. What sector does Biotheranostics operate in?

    Biotheranostics is in Biotechnology
  4. Who are Biotheranostics's competitors?

    Biotheranostics's top competitors are Biocept, NanoString, Guardant Health

Trending Companies